An observational study in Peri-Implantitis, sponsored by Kristianstad University. Completed at 1 site in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-02.
Sponsored by Kristianstad University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 21 studies in Peri-Implantitis with a site in Sweden — 5 open to participants now, 6 under way, none of them phase 3. Peri-Implantitis · Sweden.
Among the 21 studies in Peri-Implantitis with a site in Sweden, this one is the only one that started in 2000, is one of 9 observational ones, and was the 21st registered.
324 studies on the registry are indexed under Peri-Implantitis; 89 are open to participants now.
Browse Peri-Implantitis studies →5 of the 21 studies in Peri-Implantitis with a site in Sweden are open now. Recruiting first, the newest first:
Karolinska Institutet · Sites in Sweden
Ages 18+
Koite Health Oy · Sites in Sweden
Ages 18–85
Malmö University · Sites in Sweden, Austria
Ages 18–130
Kristianstad University · Sites in Sweden
Göteborg University · Sites in Sweden
Ages 18+
A study can be open while its sites in Sweden have not opened yet or have stopped. Only those recruiting at a site in Sweden →
Of the 50 Peri-Implantitis studies recruiting now, 28 (56%) set no upper age limit and 9 (18%) stop at 75 or younger; 7 take children under 18; 26 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
21 studies; the count open now beside each. This study's row is marked.
First in 2000; this study’s year is marked. 1 started in 2000.
This study's enrollment of 16 is below the median of 84 across 122 observational studies indexed under Peri-Implantitis.
Median enrollment 74 across the 12 interventional studies, 41 across the 9 observational. Of the 14 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
7 of 21 have an industry lead sponsor. The 10 most frequent:
Kristianstad University is the lead sponsor of 9 studies on the registry; 2 are open to participants now.
Kristianstad University has 2 studies filed under Peri-Implantitis — fewer than ten, so there is no comparison to draw.
3 of the studies in Peri-Implantitis with a site in Sweden that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04847648Göteborg UniversityAir-polishing in the Treatment of Peri-implantitis | 2026-12-15 |
| NCT06648564Kristianstad University20-25 Year Follow-Up on Regenerative Bone Procedures for Peri-Implantitis | 2026-12-31 |
| NCT06017817Koite Health OyAntibacterial Photodynamic Therapy in the Management of Peri-implantitis | 2026-12-31 |
Add all 3 to your calendar (.ics) → With an account.
Among the 21 studies in Peri-Implantitis with a site in Sweden, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The purpose of this 10 year observational follow-up study was to evaluate the long-term outcomes of reconstructive surgical treatment of peri-implantitis. Two treatment approaches have been compared using a bone substitute with or without a resorbable membrane.The objective was to assess their effectiveness and determine wheter one treatment strategy provided superior long-term outcomes.
Participants were invited for clinical and radiographic examinations of the previously treated implant. Clinical assessments included probing pocket depth measurements, evaluation of bleeding on probing, presence of suppuration, and radiographic assessment of peri-implant bone levels.
The objective of this 10-year observational follow-up study was to investigate the long-term clinical and radiographic outcomes of reconstructive surgical treatment and to evaluate potential differences between two reconstructive treatment protocols.
The study population consisted of patients previously treated for per-implantitis using one of the following approaches.
Group 1: Surgical treatment using a bone substitute material (Algipor) combined with a barrier membrane (Osseoquest)
Group 2: Surgical treatment using a bone substitute materail alone (Algipor)
At the time of treatment, all patients received systemic antibiotic therapy consisting of Amoxicillin 375 mg three times daily and Metronidazole 400 mg twice daily for 10 days, initiated one day before surgery.
The study aimed to provide further knowledge regarding the long-term effectiveness and stability of reconstructive peri-implantitis treatment and to investigate potential differences between the two treatment modalities.
Following surgery all patients participated in a structured supportive maintanance program with supportive periodontal therapy every third month and annual clinical evaluations.
At the 10 year follow-up examination, the implant(s) was assessed clinically and radiographically. Clinical parameters included probing pocket depht, bleeding on probing, suppuration, plaque accumulation and implant survival. Probing measurements were performed using a standardized probing force of 0.25 N with a calibrated periodontal probe.
Bleeding scores were recorded at four sites per implant using the following scale:
0=no bleeding
Plaque accumulation was recorded as present or absent, following plaque disclosure.
To minimize examiner variability, all clinical examinations was performed by the same periodontist.
The primary outcome measures were radiographic bone fill and changes in probing pocket depth at treated implant sites. Secondary outcome measures included bleeding on probing, suppuration, plaque scores, and implant survival.
Statistical analyses were performed using parametric or non-parametric methods depending on data distribution. Statistical significance was defined as p\< 0.05.
Patients received both oral and written information regarding the study and provided written informed consent prior to participation. Participation was voluntary and the participants could withdraw from the study at any time without consequences. The study had received approval from the appropiate ethical reiew authority.
Patients diagnosed with at least one dental implant with peri-implantitis
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
-
Bone reconstructive surgery with a bone graft material (Algipor) and a resorbable membrane (Osseoquest)
Procedure: Treatment with a bone graft and a membrane
Bone reconstructive surgery with a bone graft material (Algipor)
Procedure: Treatment with a bone graft
Dental implants with a diagnosis of peri-implantitis treated with reconstructive surgery and a bone graft and a membrane
Dental, implants with a diagnosis of peri.implantitis treated with reconstructive surgery and a bone graft alone
Bone fill
Radographic bone fill measured mesial and distal in mm and percent at the implant on an intra-oral radiograph. Measurements will be performed by a blinded radiologist in mm and percent
Time frame: 10 years after surgical reconstrucyive bone procedures
Probing pocket depths changes
Changes in probing pocket depths at the implant measured at four sites in mm
Time frame: 10 years after surgical reconstructive bone procedures
Bleeding
Bleeding on probing measured at the implant at four sites as present or absent
Time frame: 10 years after surgical reconstructive bone procedures
Graded bleeding
Graded bleeding measured at the implant at four sites as: 0=no bleeding 1= point of bleeding 2=line of bleeding and 3=drop of bleeding
Time frame: 10 years after surgical reconstructive bone procedures
Plan to share: Undecided — May be shared upon request
Ran from Mar 2000 to primary completion in Jan 2013, 154 months.
Of 33 non-industry observational studies under Peri-Implantitis, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 77. This study's 154 months is above that.
Counting every sponsor, half of 35 studies reached it within 17 months; a quarter within 8 and three quarters within 77.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Kristianstad University